Status:
COMPLETED
Validating a New Method to Assess Estimated Blood Loss in the Obstetric Population
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Conditions:
Pregnancy Complications
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
Postpartum hemorrhage (PPH) is the leading cause of maternal mortality in low-income countries and the primary cause of nearly one quarter of all maternal deaths globally. Estimates of blood loss at d...
Detailed Description
According to the World Health Organization, postpartum hemorrhage (PPH) is the leading cause of maternal mortality in low-income countries and the primary cause of nearly one quarter of all maternal d...
Eligibility Criteria
Inclusion
- Pregnant women between the ages of 18-50
- Scheduled cesarean delivery
Exclusion
- Incarcerated patients
- Patient unwilling or unable to provide consent
- Intrauterine fetal demise (no fetal heart beat identified and documented by two physicians)
- Placenta previa or other known placental anomalies
- Enrolled in another trial that may affect outcome.
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
242 Patients enrolled
Trial Details
Trial ID
NCT03404375
Start Date
March 1 2018
End Date
December 1 2018
Last Update
February 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Medical Branch
Galveston, Texas, United States, 77555